| Dr Julia Brooke Lowe, PHARMD | |
|
847 Boll Weivell Circle #112, Enterprise, AL 36330 | |
| (334) 348-1489 | |
| Not Available |
| Full Name | Dr Julia Brooke Lowe |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 847 Boll Weivell Circle #112, Enterprise, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417566860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21491 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia Brooke Lowe, PHARMD 847 Boll Weevil Cir Ste 112, Enterprise, AL 36330-2476 Ph: () - | Dr Julia Brooke Lowe, PHARMD 847 Boll Weivell Circle #112, Enterprise, AL 36330 Ph: (334) 348-1489 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
Young and middle-aged women experience more stress than their male counterparts, which could contribute to worse recovery from acute myocardial infarction (AMI), according to new findings by Yale School of Medicine researchers and their colleagues.
Gentium S.p.A. today announced final clinical trial results from the Company's Phase II/III Pediatric Prevention trial and Phase III Treatment trial for Defibrotide of Hepatic Veno-Occlusive Disease (VOD), which were presented at the American Society of Hematology Conference (ASH) in New Orleans.
› Verified 4 days ago
Joseph Paul Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 E Brunson St, Enterprise, AL 36330 Phone: 334-347-6865 Fax: 334-393-0679 | |
Christine Anne Mcculley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Edwards St, Enterprise, AL 36330 Phone: 334-347-1202 | |
Dr. Michele L Garrett Iv, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Fort Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 | |
Mr. Gregory Larkin Goodson, NRPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 N Main St, Suite A, Enterprise, AL 36330 Phone: 334-393-0086 Fax: 334-393-0206 | |
Gladys Theiler, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 Fax: 393-393-1386 | |
Cheryl Massey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-4440 Fax: 334-393-2449 | |
Natasha Lynn Rosekrans, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 Boll Weevil Cir, Enterprise, AL 36330 Phone: 334-389-3143 |